Literature DB >> 8443379

Cooperative effects of interleukin-3 (IL-3), IL-5, and granulocyte-macrophage colony-stimulating factor: a new myeloid cell line inducible to eosinophils.

C C Paul1, M Tolbert, S Mahrer, A Singh, M J Grace, M A Baumann.   

Abstract

The cytokines interleukin-3 (IL-3); IL-5, and granulocyte-macrophage colony-stimulating factor (GM-CSF) are known to contribute to the proliferation and differentiation of eosinophil progenitors. Recently, it was determined that the cellular receptors for these three cytokines share a common beta-chain while having unique alpha-chains. Thus, there is considerable interest in how these cytokines and their receptors interact in promoting production of eosinophils. We have established a cell line (AML14) from a patient with acute myelogenous leukemia that will consistently exhibit eosinophilic differentiation in suspension in response to IL-3, IL-5, and GM-CSF. Proliferation with only modest differentiative effects was observed in response to a single cytokine. Combinations of two cytokines gave variable results, with GM-CSF + IL-3 and IL-3 + IL-5 causing more proliferation than a single cytokine but little more differentiation. The combination of GM-CSF + IL-5 caused marked enhancement of eosinophilic differentiation with only modest augmentation of proliferation. The combination of all three cytokines was most effective in stimulating both proliferation and eosinophilic differentiation (up to 70% of cells) of AML14 cells. Specific binding of GM-CSF and IL-5 to AML14 cells can be conveniently studied by flow cytometric methods, and cross-competition of these two cytokines for their respective receptors was demonstrated. IL-3 was shown to partially compete for IL-5 binding on AML14 cells. Although specific IL-3 binding could not be demonstrated by flow cytometry, mRNA for the alpha-chains of the IL-3, IL-5, and GM-CSF receptors and the beta-chain common to all three receptors was detected in AML14 cells. The AML14 cell line may be a useful model for the study of cooperative interactions of IL-3, IL-5, GM-CSF, and their respective receptors in the promotion of eosinophil progenitor growth and differentiation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8443379

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Dimeric RFX proteins contribute to the activity and lineage specificity of the interleukin-5 receptor alpha promoter through activation and repression domains.

Authors:  A Iwama; J Pan; P Zhang; W Reith; B Mach; D G Tenen; Z Sun
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

Review 2.  Human eosinophils and mast cells: Birds of a feather flock together.

Authors:  Piper A Robida; Pier Giorgio Puzzovio; Hadas Pahima; Francesca Levi-Schaffer; Bruce S Bochner
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

Review 3.  Mechanism of eosinophilic esophagitis.

Authors:  Anil Mishra
Journal:  Immunol Allergy Clin North Am       Date:  2009-02       Impact factor: 3.479

4.  Phosphatidylserine index as a marker of the procoagulant phenotype of acute myelogenous leukemia cells.

Authors:  Garth W Tormoen; Olivia Recht; András Gruber; Ross L Levine; Owen J T McCarty
Journal:  Phys Biol       Date:  2013-10-08       Impact factor: 2.583

5.  Ribosomal p70S6K basal activity increases upon induction of differentiation of myelomonocytic leukemic cell lines HL60, AML14 and MPD.

Authors:  Julian Gomez-Cambronero; Tricia Frye; Michael Baumann
Journal:  Leuk Res       Date:  2004-07       Impact factor: 3.156

6.  Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development.

Authors:  K Kaushansky; V C Broudy; N Lin; M J Jorgensen; J McCarty; N Fox; D Zucker-Franklin; C Lofton-Day
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

7.  Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils.

Authors:  Kenji Ishihara; JangJa Hong; OkPyo Zee; Kazuo Ohuchi
Journal:  Br J Pharmacol       Date:  2004-06-21       Impact factor: 8.739

8.  Charcot-Leyden crystal protein/galectin-10 interacts with cationic ribonucleases and is required for eosinophil granulogenesis.

Authors:  Milica M Grozdanovic; Christine B Doyle; Li Liu; Brian T Maybruck; Mark A Kwatia; Nethaji Thiyagarajan; K Ravi Acharya; Steven J Ackerman
Journal:  J Allergy Clin Immunol       Date:  2020-01-23       Impact factor: 10.793

9.  JAK2 ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia vera.

Authors:  Ami B Patel; Anca Franzini; Emilie Leroy; Soo Jin Kim; Anthony D Pomicter; Lidvine Genet; Michael Xiao; Dongqing Yan; Jonathan M Ahmann; Archana M Agarwal; Phillip Clair; Juanah Addada; Jonathan Lambert; Matthew Salmon; Gerald J Gleich; Nicholas C P Cross; Stefan N Constantinescu; Thomas O'Hare; Josef T Prchal; Michael W Deininger
Journal:  Blood       Date:  2019-12-26       Impact factor: 25.476

10.  Analysis of the CCR3 promoter reveals a regulatory region in exon 1 that binds GATA-1.

Authors:  Nives Zimmermann; Jessica L Colyer; Laura E Koch; Marc E Rothenberg
Journal:  BMC Immunol       Date:  2005-04-04       Impact factor: 3.615

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.